Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × BCG Vaccine × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Side Effect of Drug 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Gemcitabine 7 erdafitinib 4 Mitomycin 4 dodecyl maltoside 2 Docetaxel 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Epirubicin 1 Drainage 1 Cystoscopy 1 BCG Vaccine 1 Accelerometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05538663 2026-03-02

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡